0 items USD 0.00Search
Your search for "gallium nitride (GaN)" gave back 194 results.
The global Biologics and Biosimilars market size is predicted to grow from US$ 465450 million in 2025 to US$ 780800 million in 2031; it is expected...
颁补迟补濒辞驳:听
LPI
March 2025
Price: USD 3,660.00
The global Glargine Insulin Pen market size was valued at US$ million in 2023. With growing demand in downstream market, the Glargine Insulin Pen is...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
The global Insulin Biosimilars market size was valued at US$ 1447.8 million in 2023. With growing demand in downstream market, the Insulin...
颁补迟补濒辞驳:听
LPI
December 2024
Price: USD 3,660.00
The global Diabetes Drugs market size was valued at US$ 100230 million in 2024 and is forecast to a readjusted size of USD 210010 million by 2031...
颁补迟补濒辞驳:听
GIR
February 2025
Price: USD 3,480.00
The global Diabetes Medicines market size was valued at US$ 100230 million in 2024 and is forecast to a readjusted size of USD 210010 million by 2031...
颁补迟补濒辞驳:听
GIR
January 2025
Price: USD 3,480.00
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones,...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
The global Biologics and Biosimilars market size was valued at US$ 454100 million in 2024 and is forecast to a readjusted size of USD 797670 million...
颁补迟补濒辞驳:听
GIR
June 2025
Price: USD 3,480.00
Premixed Insulin Analogs refer to an insulin preparation made by mixing a rapid-acting insulin analog(lispro insulin or aspart insulin)with a...
颁补迟补濒辞驳:听
LPI
August 2024
Price: USD 3,660.00
Mealtime insulin specifically refers to the administration of insulin just before meals to control blood sugar levels that rise in response to food...
颁补迟补濒辞驳:听
LPI
August 2024
Price: USD 3,660.00
The global market for GLP-1 Weight Loss Pill was valued at US$ 1214 million in the year 2023 and is projected to reach a revised size of US$ 2465...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 2,900.00
The global Insulin Glargine and Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with...
颁补迟补濒辞驳:听
GIR
December 2024
Price: USD 3,480.00
The global market for Ultra Short Acting Insulin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 3,950.00
The global Insulin Biosimilars market size was valued at USD 1522.8 million in 2023 and is forecast to a readjusted size of USD 1917.9 million by...
颁补迟补濒辞驳:听
GIR
December 2024
Price: USD 3,480.00
DPP-4 inhibitor hypoglycemic drugs can not only reduce the blood sugar concentration of patients, but also promote insulin secretion, and even repair...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
听
